MIRIAM LEVITT: Open Payments
NPI 1447247820 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,378 in 82 payments from 18 companies in 2025. Trend: 2023 $1,885 · 2024 $1,780 · 2025 $1,378
Food & beverage: $1,378
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 34 | $303 |
| AstraZeneca Pharmaceuticals LP | 9 | $257 |
| ABBVIE INC. | 4 | $88 |
| PFIZER INC. | 4 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $85 |
| Sumitomo Pharma America, Inc. | 4 | $73 |
| Exact Sciences Corporation | 2 | $64 |
| Abbott Laboratories | 3 | $55 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Astellas Pharma US Inc | 3 | $50 |
Products named: OTEZLA, BREZTRI, XIFAXAN, GEMTESA, NURTEC ODT, The Cologuard Plus Collection Kit, FREESTYLE LIBRE 3, SHINGRIX.
Industry payments across CA — which companies pay providers there.
